NYSE:CLB - Core Laboratories Stock Price, News, & Analysis

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories announced a quarterly dividend on Tuesday, April 16th. Stockholders of record on Friday, April 26th will be given a dividend of $0.55 per share on Tuesday, May 21st. This represents a $2.20 dividend on an annualized basis and a dividend yield of 2.95%. The ex-dividend date is Thursday, April 25th. View Core Laboratories' Dividend History.

Core Laboratories (NYSE:CLB) posted its quarterly earnings data on Wednesday, January, 30th. The oil and gas company reported $0.48 earnings per share for the quarter, missing analysts' consensus estimates of $0.49 by $0.01. The oil and gas company earned $173.20 million during the quarter, compared to the consensus estimate of $173.90 million. Core Laboratories had a return on equity of 63.86% and a net margin of 11.35%. The company's revenue was up 1.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.58 earnings per share. View Core Laboratories' Earnings History.

Core Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, April 24th 2019. View Earnings Estimates for Core Laboratories.

Core Laboratories will be holding an earnings conference call on Thursday, April 25th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Core Laboratories updated its first quarter earnings guidance on Wednesday, January, 30th. The company provided earnings per share guidance of $0.42-0.45 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.42. The company issued revenue guidance of $164-168 million, compared to the consensus revenue estimate of $165.34 million.Core Laboratories also updated its Q1 2019 guidance to $0.42-0.45 EPS.

15 brokers have issued 12 month price targets for Core Laboratories' shares. Their predictions range from $66.00 to $130.00. On average, they expect Core Laboratories' share price to reach $90.90 in the next year. This suggests a possible upside of 21.9% from the stock's current price. View Analyst Price Targets for Core Laboratories.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 8 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Core Laboratories.

Media stories about CLB stock have been trending positive on Tuesday, InfoTrie reports. The research group scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Core Laboratories earned a daily sentiment score of 2.7 on InfoTrie's scale. They also assigned press coverage about the oil and gas company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future.

Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), RPC (RES), Propetro (PUMP), Liberty Oilfield Services (LBRT), Oceaneering International (OII), Franks International (FI), Select Energy Services (WTTR), FTS International (FTSI), Helix Energy Solutions Group (HLX), Keane Group (FRAC), SemGroup (SEMG), C&J Energy Services (CJ), National Energy Services Reunited (NESR), Mammoth Energy Services (TUSK) and Superior Energy Services (SPN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Starbucks (SBUX), NIC (EGOV), Athabasca Oil (ATH), Baidu (BIDU) and Aegean Marine Petroleum Network (ANW).

Core Laboratories' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Douglas Lane & Associates LLC (0.15%), Howland Capital Management LLC (0.14%), Retirement Systems of Alabama (0.13%), BTIM Corp. (0.12%), Scout Investments Inc. (0.11%) and Clear Harbor Asset Management LLC (0.09%). Company insiders that own Core Laboratories stock include Jan Willem Sodderland and Kevin Daniels. View Institutional Ownership Trends for Core Laboratories.

CLB stock was sold by a variety of institutional investors in the last quarter, including Howland Capital Management LLC, BTIM Corp., Loring Wolcott & Coolidge Fiduciary Advisors LLP MA, Manning & Napier Group LLC, Clear Harbor Asset Management LLC, Gofen & Glossberg LLC IL, BB&T Corp and Forte Capital LLC ADV. View Insider Buying and Selling for Core Laboratories.

CLB stock was bought by a variety of institutional investors in the last quarter, including Scout Investments Inc., Douglas Lane & Associates LLC, Brinker Capital Inc., Triangle Securities Wealth Management, Triangle Securities Wealth Management, Ridgewood Investments LLC, Conestoga Capital Advisors LLC and Eqis Capital Management Inc.. View Insider Buying and Selling for Core Laboratories.

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CLB stock can currently be purchased for approximately $74.56.

Core Laboratories has a market capitalization of $3.31 billion and generates $700.84 million in revenue each year. Core Laboratories employs 4,700 workers across the globe.

The official website for Core Laboratories is http://www.corelab.com.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]